Myocarditis (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Myocarditis" in Dutch language version.

Last modified: 07:59:19, 19 December 2025 (UTC)

Ref.Un. Ref.Website

Global rank Dutch rank

1^st place

1,078^th place

1,528^th place

low place

5^th place

15^th place

medscape.com (Global: 1,078^th place; Dutch: 1,528^th place)

(en) Mayara Bearse; Yin P Hung, Aram J Krauson, Liana Bonanno, Baris Boyraz, Cynthia K Harris, T Leif Helland, Caroline F Hilburn, Bailey Hutchison, Soma Jobbagy, Michael S Marshall, Daniel J Shepherd, Julian A Villalba, Isabela Delfino, Javier Mendez-Pena, Ivan Chebib, Christopher Newton-Cheh, James R Stone, Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19. National Center for Biotechnology Information (2021). Gearchiveerd op 12 mei 2022. Geraadpleegd op 12 oktober 2022. “In summary, cardiac infection with SARS-CoV-2 is common among patients dying from COVID-19 but often with only rare infected cells.”

(en) Myocarditis and Pericarditis after COVID-19 mRNA Vaccines (november 2021). Gearchiveerd op 20 januari 2022. Geraadpleegd op 28 januari 2022.

Medscape: Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Gearchiveerd op 23 januari 2025.
(en) Myocarditis and Pericarditis after COVID-19 mRNA Vaccines (november 2021). Gearchiveerd op 20 januari 2022. Geraadpleegd op 28 januari 2022.
(en) Mayara Bearse; Yin P Hung, Aram J Krauson, Liana Bonanno, Baris Boyraz, Cynthia K Harris, T Leif Helland, Caroline F Hilburn, Bailey Hutchison, Soma Jobbagy, Michael S Marshall, Daniel J Shepherd, Julian A Villalba, Isabela Delfino, Javier Mendez-Pena, Ivan Chebib, Christopher Newton-Cheh, James R Stone, Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19. National Center for Biotechnology Information (2021). Gearchiveerd op 12 mei 2022. Geraadpleegd op 12 oktober 2022. “In summary, cardiac infection with SARS-CoV-2 is common among patients dying from COVID-19 but often with only rare infected cells.”